Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines-a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems

被引:40
作者
Bauer, S. [1 ]
Nauck, M. A. [1 ]
机构
[1] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany
关键词
MEDICATION ADHERENCE; MORTALITY; THERAPY; HYPERGLYCEMIA; MANAGEMENT; MELLITUS; OUTCOMES; DISEASE;
D O I
10.1111/dme.12497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Our aim was to assess the number of medications prescribed to people with Type 1 or Type 2 diabetes mellitus and to compare these to recommendations by guidelines. Patients and methods Data from 155 and 154 people with Type 1 and Type 2 diabetes, respectively, were analysed. Prescribed medications (glucose-lowering drugs, blood pressure medications, drugs to treat cardiovascular risk or diseases, etc.) were counted as compounds per day, tablets per day, injections per day, or other modes of administration. Results People with Type 2 diabetes were prescribed 8.4 +/- 3.0 different drug compounds per day (maximum, 16), 8.6 +/- 3.9 tablets per day (maximum, 22), 2.6 +/- 1.6 injections per day (maximum, 7), in total 11.6 +/- 4.5 doses of any medication per day (maximum, 27). The numbers for people with Type 1 diabetes were 5.5 +/- 3.4 compounds per day (maximum, 15), 4.5 +/- 4.3 tablets per day (maximum, 18), 3.9 +/- 2.2 injections per day (maximum, 8), in total 8.5 +/- 5.1 doses of any medication per day (maximum, 22). Over 97% of the prescriptions corresponded to recommendations by guidelines. Conclusions The number of prescribed drugs is high in people with diabetes mellitus, and higher for those with Type 2 than with Type 1 diabetes. The compatibility of prescriptions with guideline recommendations suggests that even this high number of prescriptions will provide a clinical benefit. The current analysis could provide a basis for a realistic judgement of the burden imposed by polypharmacy in people with diabetes mellitus.
引用
收藏
页码:1078 / 1085
页数:8
相关论文
共 30 条
[1]   Diabetic Patients' Medication Underuse, Illness Outcomes, and Beliefs About Antihyperglycemic and Antihypertensive Treatments [J].
Aikens, James E. ;
Piette, John D. .
DIABETES CARE, 2009, 32 (01) :19-24
[2]  
[Anonymous], 2011, S3 LEITLINIE THERAPI
[3]   A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes [J].
Asche, Carl ;
LaFleur, Joanne ;
Conner, Christopher .
CLINICAL THERAPEUTICS, 2011, 33 (01) :74-109
[4]   Polypharmacy: Correlations with sex, age and drug regimen - A prescription database study [J].
Bjerrum, L ;
Sogaard, J ;
Hallas, J ;
Kragstrup, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :197-202
[5]   DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BOJESTIG, M ;
ARNQVIST, HJ ;
HERMANSSON, G ;
KARLBERG, BE ;
LUDVIGSSON, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (01) :15-18
[6]  
Bundesarztekammer ( BAK) Kassenarztliche Bundesvereinigung ( KBV) and Arbeitsgemeinschaft der Wissenschaftlichen Medizinis- chen Fachgesellschaften ( AWMF), 2013, NAT GUID CHRON COR H
[7]  
Bundesarztekammer ( BAK) Kassenarztliche Bundesvereinigung ( KBV) and Arbeitsgemeinschaft der Wissenschaftlichen Medizinis- chen Fachgesellschaften ( AWMF), 2013, NAT GUID CHRON HEART
[8]   A systematic review of the associations between dose regimens and medication compliance [J].
Claxton, AJ ;
Cramer, J ;
Pierce, C .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1296-1310
[9]   A systematic review of adherence with medications for diabetes [J].
Cramer, JA .
DIABETES CARE, 2004, 27 (05) :1218-1224
[10]  
Deutsche Hochdruckliga and Deutsche Hypertonie Gesellschaft Leitlinien zur Behandlung der arteriellen Hypertonie (German League against arterial hypertension and German Association for hypertension Guidelines for the management of arterial hypertension), 2008, DTSCH HOCHDR DTSCH H